22 results
6-K
EX-99.2
PPBT
Purple Biotech Ltd
22 Aug 23
Purple Biotech Reports Second Quarter 2023 Financial Results
8:22am
of Directors has overall responsibility for the establishment and oversight of the Group’s risk management framework.
The Group’s risk management
6-K
EX-99.2
PPBT
Purple Biotech Ltd
4 Aug 22
Purple Biotech Reports Second Quarter 2022 Financial Results
7:31am
Framework for risk management
The Board of Directors has overall responsibility for the establishment and oversight of the Group’s risk management
6-K
EX-99.2
PPBT
Purple Biotech Ltd
5 Aug 21
Purple Biotech Provides Corporate Update and Reports First Half 2021 Financial Results
8:33am
for the establishment and oversight of the Group’s risk management framework.
The Group's risk management practice was formulated to identify and analyze
6-K
EX-1.1
qsjap3k2212p1zv9oqf6
9 Jun 21
Report of Foreign Private Issuer
5:06pm
20-F/A
nx6wx
16 Mar 21
Annual report (foreign) (amended)
3:22pm
6-K
EX-99.2
so6h1z5
11 Aug 20
Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Results
8:22am
424B4
692lfgd
16 Mar 20
Prospectus supplement with pricing info
6:08am
F-1/A
3iwzm5ha ctph3r
11 Mar 20
Registration statement (foreign) (amended)
9:16am
F-1/A
tdt1nqugc1
10 Mar 20
Registration statement (foreign) (amended)
8:13am
F-1
78an5d2ribc2k7nz alb
27 Dec 19
Registration statement (foreign)
4:09pm
6-K
EX-99.2
5g5icjrx0wqdn
8 Aug 19
Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update
4:32pm
424B5
uy6yspupu 7t7lwdbj
18 Jan 19
Prospectus supplement for primary offering
12:03pm
424B5
i63mr8my
5 Jun 18
Prospectus supplement for primary offering
1:45pm
424B5
ox8j87xcrmntsuzko
13 Jul 17
Prospectus supplement for primary offering
12:00am